17 August 2018 Immunicum AB (publ) Interim Report April - June 2018 Significant Events During the Second Quarter
Immunicum announced Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research .
End of Enrollment in Phase I/II GIST Clinical Trial .
Immunicum provided an update o